Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Kaliberov SA, Kaliberova LN, Hong Lu Z, Preuss MA, Barnes JA, Stockard CR, Grizzle WE, Arbeit JM, Curiel DT.

Virology. 2013 Dec;447(1-2):312-25. doi: 10.1016/j.virol.2013.09.020. Epub 2013 Oct 15.

2.

Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.

Kim H, Rigell CJ, Zhai G, Lee SK, Samuel SL, Martin A, Umphrey HR, Stockard CR, Beasley TM, Buchsbaum DJ, Li LS, Boothman DA, Zinn KR.

Mol Imaging Biol. 2014 Feb;16(1):85-94. doi: 10.1007/s11307-013-0665-4. Epub 2013 Jul 9.

3.

Diffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat model.

Zhai G, Grubbs CJ, Stockard CR, Umphrey HR, Beasley TM, Kim H.

PLoS One. 2013 May 21;8(5):e64445. doi: 10.1371/journal.pone.0064445. Print 2013.

4.

Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.

Kerr EH, Frederick PJ, Egger ME, Stockard CR, Sellers J, DellaManna D, Oelschlager DK, Amm HM, Eltoum IE, Straughn JM, Buchsbaum DJ, Grizzle WE, McNally LR.

Ann Surg Oncol. 2013 Sep;20(9):3059-65. doi: 10.1245/s10434-013-2878-9. Epub 2013 Mar 24.

PMID:
23525731
5.

Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol.

Otali D, He Q, Stockard CR, Grizzle WE.

Biotech Histochem. 2013 May;88(3-4):170-80. doi: 10.3109/10520295.2012.754496. Epub 2013 Jan 23.

6.

Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.

Kim H, Zhai G, Samuel SL, Rigell CJ, Umphrey HR, Rana S, Stockard CR, Fineberg NS, Zinn KR.

Mol Cancer Ther. 2012 Feb;11(2):405-15. doi: 10.1158/1535-7163.MCT-11-0581. Epub 2011 Dec 27.

7.

Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.

Kim H, Zhai G, Liu Z, Samuel S, Shah N, Helman EE, Knowles JA, Stockard CR, Fineberg NS, Grizzle WE, Zhou T, Zinn KR, Rosenthal EL.

Anticancer Drugs. 2011 Oct;22(9):864-74. doi: 10.1097/CAD.0b013e328349311e.

8.

Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.

Singh R, Stockard CR, Grizzle WE, Lillard JW Jr, Singh S.

Int J Oncol. 2011 Aug;39(2):373-81. doi: 10.3892/ijo.2011.1059. Epub 2011 May 31.

9.

Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging.

Kim H, Folks KD, Guo L, Sellers JC, Fineberg NS, Stockard CR, Grizzle WE, Buchsbaum DJ, Morgan DE, George JF, Zinn KR.

Mol Imaging. 2011 Jun;10(3):153-67.

10.

(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts.

Shah N, Zhai G, Knowles JA, Stockard CR, Grizzle WE, Fineberg N, Zhou T, Zinn KR, Rosenthal EL, Kim H.

Mol Imaging Biol. 2012 Apr;14(2):237-44. doi: 10.1007/s11307-011-0491-5.

11.

CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.

Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, Lillard JW Jr.

Int J Oncol. 2011 May;38(5):1279-85. doi: 10.3892/ijo.2011.953. Epub 2011 Feb 23.

12.

Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice.

Hsu HC, Yang P, Wu Q, Wang JH, Job G, Guentert T, Li J, Stockard CR, Le TV, Chaplin DD, Grizzle WE, Mountz JD.

Arthritis Rheum. 2011 Jul;63(7):2038-48. doi: 10.1002/art.30257.

13.

A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases.

Kimball KJ, Preuss MA, Barnes MN, Wang M, Siegal GP, Wan W, Kuo H, Saddekni S, Stockard CR, Grizzle WE, Harris RD, Aurigemma R, Curiel DT, Alvarez RD.

Clin Cancer Res. 2010 Nov 1;16(21):5277-87. doi: 10.1158/1078-0432.CCR-10-0791. Epub 2010 Oct 26.

14.

KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.

McNally LR, Welch DR, Beck BH, Stafford LJ, Long JW, Sellers JC, Huang ZQ, Grizzle WE, Stockard CR, Nash KT, Buchsbaum DJ.

Clin Exp Metastasis. 2010 Dec;27(8):591-600. doi: 10.1007/s10585-010-9349-5. Epub 2010 Sep 16.

15.

DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy.

Kim H, Folks KD, Guo L, Stockard CR, Fineberg NS, Grizzle WE, George JF, Buchsbaum DJ, Morgan DE, Zinn KR.

Mol Imaging Biol. 2011 Feb;13(1):94-103. doi: 10.1007/s11307-010-0320-2.

16.

Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.

Kaliberova LN, Kusmartsev SA, Krendelchtchikova V, Stockard CR, Grizzle WE, Buchsbaum DJ, Kaliberov SA.

Mol Cancer Ther. 2009 Nov;8(11):3130-9. doi: 10.1158/1535-7163.MCT-09-0270. Epub 2009 Nov 3.

17.

Combined effects of formalin fixation and tissue processing on immunorecognition.

Otali D, Stockard CR, Oelschlager DK, Wan W, Manne U, Watts SA, Grizzle WE.

Biotech Histochem. 2009 Oct;84(5):223-47. doi: 10.3109/10520290903039094.

18.

Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis.

Xu X, Hsu HC, Chen J, Grizzle WE, Chatham WW, Stockard CR, Wu Q, Yang PA, Holers VM, Mountz JD.

Scand J Immunol. 2009 Sep;70(3):309-16. doi: 10.1111/j.1365-3083.2009.02302.x.

19.

Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.

Frederick PJ, Kendrick JE, Straughn JM Jr, Della Manna DL, Oliver PG, Lin HY, Grizzle WE, Stockard CR, Alvarez RD, Zhou T, LoBuglio AF, Buchsbaum DJ.

Int J Gynecol Cancer. 2009 Jul;19(5):814-9. doi: 10.1111/IGC.0b013e3181a2a003.

PMID:
19574765
20.

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

Kaliberova LN, Krendelchtchikova V, Harmon DK, Stockard CR, Petersen AS, Markert JM, Gillespie GY, Grizzle WE, Buchsbaum DJ, Kaliberov SA.

Cancer Gene Ther. 2009 Oct;16(10):794-805. doi: 10.1038/cgt.2009.23. Epub 2009 Apr 10.

21.

Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.

Liu K, Bellam N, Lin HY, Wang B, Stockard CR, Grizzle WE, Lin WC.

Mol Cell Biol. 2009 May;29(10):2673-93. doi: 10.1128/MCB.01140-08. Epub 2009 Mar 16.

22.

Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.

Zhang J, Luo B, Tang L, Wang Y, Stockard CR, Kadish I, Van Groen T, Grizzle WE, Ponnazhagan S, Fallon MB.

Gastroenterology. 2009 Mar;136(3):1070-80. doi: 10.1053/j.gastro.2008.12.001. Epub 2008 Dec 3.

23.

Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.

Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR.

Cancer Res. 2008 Oct 15;68(20):8369-76. doi: 10.1158/0008-5472.CAN-08-1771.

24.

Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Wang D, Stockard CR, Harkins L, Lott P, Salih C, Yuan K, Buchsbaum D, Hashim A, Zayzafoon M, Hardy RW, Hameed O, Grizzle W, Siegal GP.

Biotech Histochem. 2008 Jun;83(3-4):179-89. doi: 10.1080/10520290802451085.

25.

Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody.

Kim H, Morgan DE, Zeng H, Grizzle WE, Warram JM, Stockard CR, Wang D, Zinn KR.

Radiology. 2008 Sep;248(3):844-51. doi: 10.1148/radiol.2483071740.

26.

Effect of exercise and calorie restriction on biomarkers of aging in mice.

Huffman DM, Moellering DR, Grizzle WE, Stockard CR, Johnson MS, Nagy TR.

Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1618-27. doi: 10.1152/ajpregu.00890.2007. Epub 2008 Mar 5.

27.

Antibody responses of variable lymphocyte receptors in the lamprey.

Alder MN, Herrin BR, Sadlonova A, Stockard CR, Grizzle WE, Gartland LA, Gartland GL, Boydston JA, Turnbough CL Jr, Cooper MD.

Nat Immunol. 2008 Mar;9(3):319-27. doi: 10.1038/ni1562. Epub 2008 Feb 3.

PMID:
18246071
28.

Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.

Kendrick JE, Straughn JM Jr, Oliver PG, Wang W, Nan L, Grizzle WE, Stockard CR, Alvarez RD, Buchsbaum DJ.

Gynecol Oncol. 2008 Mar;108(3):591-7. doi: 10.1016/j.ygyno.2007.11.039. Epub 2008 Jan 4.

PMID:
18177927
29.

Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change.

Mackenzie KF, Topping EC, Bugaj-Gaweda B, Deng C, Cheung YF, Olsen AE, Stockard CR, High Mitchell L, Baillie GS, Grizzle WE, De Vivo M, Houslay MD, Wang D, Bolger GB.

Biochem J. 2008 Apr 15;411(2):361-9.

30.

TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth.

Derosier LC, Vickers SM, Zinn KR, Huang Z, Wang W, Grizzle WE, Sellers J, Stockard CR Jr, Zhou T, Oliver PG, Arnoletti P, Lobuglio AF, Buchsbaum DJ.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3198-207.

31.

Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice.

Grizzle WE, Xu X, Zhang S, Stockard CR, Liu C, Yu S, Wang J, Mountz JD, Zhang HG.

Mech Ageing Dev. 2007 Nov-Dec;128(11-12):672-80. Epub 2007 Oct 22.

PMID:
18036633
32.

Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model.

Estes JM, Oliver PG, Straughn JM Jr, Zhou T, Wang W, Grizzle WE, Alvarez RD, Stockard CR, LoBuglio AF, Buchsbaum DJ.

Gynecol Oncol. 2007 May;105(2):291-8. Epub 2007 Feb 15.

PMID:
17303227
33.

Methionine inhibits cellular growth dependent on the p53 status of cells.

Benavides MA, Oelschlager DK, Zhang HG, Stockard CR, Vital-Reyes VS, Katkoori VR, Manne U, Wang W, Bland KI, Grizzle WE.

Am J Surg. 2007 Feb;193(2):274-83.

PMID:
17236862
34.

Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.

Baker AC, Eltoum I, Curry RO, Stockard CR, Manne U, Grizzle WE, Chhieng D.

Arch Pathol Lab Med. 2006 Oct;130(10):1510-5.

PMID:
17090193
35.

Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.

Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, Sun JZ, Stockard CR, Frost AR, Chen YF, Grizzle WE, Fallon MB.

Gastroenterology. 2005 Aug;129(2):682-95.

36.

Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells.

Li Q, Wu L, Oelschlager DK, Wan M, Stockard CR, Grizzle WE, Wang N, Chen H, Sun Y, Cao X.

J Biol Chem. 2005 Jul 22;280(29):27022-8. Epub 2005 May 10.

37.

Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.

Kaliberov SA, Kaliberova LN, Stockard CR, Grizzle WE, Buchsbaum DJ.

Mol Ther. 2004 Dec;10(6):1059-70.

38.

The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.

Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, Stockard CR, Grizzle WE, Ku DD, Fallon MB.

Hepatology. 2004 Jun;39(6):1593-602.

PMID:
15185300
39.
40.

IL-12 inhibits thymic involution by enhancing IL-7- and IL-2-induced thymocyte proliferation.

Li L, Hsu HC, Stockard CR, Yang P, Zhou J, Wu Q, Grizzle WE, Mountz JD.

J Immunol. 2004 Mar 1;172(5):2909-16.

41.

p53 and erbB-2 are not associated in matched cases of primary and metastatic ovarian carcinomas.

Rodríguez-Burford C, Chhieng DC, Stockard CR, Kleinberg MJ, Barnes MN, Partridge EE, Weiss HL, Grizzle WE.

Dis Markers. 2003-2004;19(1):11-7.

42.

Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma.

Chhieng DC, Rodriguez-Burford C, Talley LI, Sviglin H, Stockard CR, Kleinberg MJ, Barnes MN, Partridge EE, Khazaeli MB, Grizzle WE.

Hum Pathol. 2003 Oct;34(10):1016-21.

PMID:
14608535
43.

Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.

Zhang J, Ling Y, Luo B, Tang L, Ryter SW, Stockard CR, Grizzle WE, Fallon MB.

Gastroenterology. 2003 Nov;125(5):1441-51.

PMID:
14598260
44.

Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcript.

Blume SW, Miller DM, Guarcello V, Shrestha K, Meng Z, Snyder RC, Grizzle WE, Ruppert JM, Gartland GL, Stockard CR, Jones DE Jr, Emanuel PD.

Exp Cell Res. 2003 Aug 1;288(1):131-42.

PMID:
12878165
45.

Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.

Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Haisma HJ, Alvarez RD, Curiel DT.

Clin Cancer Res. 2003 Jul;9(7):2701-10.

46.

Cellular mechanism of thymic involution.

Li L, Hsu HC, Grizzle WE, Stockard CR, Ho KJ, Lott P, Yang PA, Zhang HG, Mountz JD.

Scand J Immunol. 2003 May;57(5):410-22. Erratum in: Scand J Immunol. 2003 Jul;58(1):118. William, GE [corrected to Grizzle, WE].

48.

Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.

Rodríguez-Burford C, Steele VE, Anderson AS, Stockard CR, Weiss HL, Eto I, Johanning GL, Grizzle WE, Grubbs CJ.

Nutr Cancer. 2002;43(1):67-75.

PMID:
12467137
49.
50.

Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.

Swanson SM, Whitaker LM, Stockard CR, Myers RB, Oelschlager D, Grizzle WE, Juliana MM, Grubbs CJ.

Anticancer Res. 1997 Nov-Dec;17(6D):4639-45.

PMID:
9494582

Supplemental Content

Loading ...
Support Center